ARTICLE | Clinical News
Masitinib: Phase II ongoing
August 17, 2015 7:00 AM UTC
AB Science said an independent DSMB recommended for a second time continuation of a Phase II trial evaluating oral masitinib in combination with etoposide or irinotecan in patients who relapsed after ...